Party's Politburo member Brinda Karat, who had taken on Ramdev earlier too, said there was an online discussion on the 'Putrajeevak Beej' medicine suggesting that it helps produce a son, and this was "branding on part of Ramdev".
"Clearly, this is how he is branding the drug. This is completely against the PNDT (Pre-Natal Diagnostic Techniques) Act. It is outside the ambit of the law. And he should be prosecuted for this...On two grounds, one the PNDT Act and two, even the Consumer Protection Act.
Karat had taken on Ramdev earlier when she had alleged that medicines his pharmacy produced contained human bones and animal parts.
Opposition MPs led by JD(U)'s K C Tyagi had yesterday sought a ban on the product and sought stringent action against the manufacturer in the Rajya Sabha.
Earlier today, the yoga guru had rebutted charges that the medicine was being sold for conceiving a male child and claimed that he was being targeted through "lies" to defame the Prime Minister.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
